HomeBCAX • NASDAQ
add
Bicara Therapeutics Inc
Previous close
$11.03
Day range
$10.37 - $11.84
Year range
$7.80 - $28.08
Market cap
627.17M USD
Avg Volume
1.12M
P/E ratio
0.81
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 41.79M | 171.81% |
Net income | -36.85M | -194.58% |
Net profit margin | — | — |
Earnings per share | -0.68 | — |
EBITDA | -41.77M | -171.92% |
Effective tax rate | -0.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 462.06M | 100.51% |
Total assets | 478.08M | — |
Total liabilities | 19.12M | — |
Total equity | 458.96M | — |
Shares outstanding | 54.54M | — |
Price to book | 1.31 | — |
Return on assets | -21.15% | — |
Return on capital | -21.94% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -36.85M | -194.58% |
Cash from operations | -28.11M | -92.68% |
Cash from investing | — | — |
Cash from financing | 460.00K | 235.77% |
Net change in cash | -27.65M | -92.09% |
Free cash flow | -17.37M | — |
About
Founded
2018
Headquarters
Website
Employees
55
